NS
PRME icon

NBC Securities’s Prime Medicine PRME Stock Holding History

NBC Securities’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.9K Buy
10,000
+5,000
+100% +$16.6K ﹤0.01% 1409
2026
Q1 		$17.4K Hold
5,000
– – ﹤0.01% 1761
2025
Q4 		$17.4K Sell
5,000
-2,500
-33% -$11.1K ﹤0.01% 1829
2025
Q3 		$41.5K Buy
+7,500
New +$30.5K ﹤0.01% 1403

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

NBC Securities's PRME Position: Q2 2026 in Review

NBC Securities increased its Prime Medicine (PRME) stake by 100% in Q2 2026, buying an estimated $16.6K and bringing the position to 10,000 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

NBC Securities first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $41.5K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • NBC Securities held 10,000 shares of Prime Medicine worth $36.9K as of Q2 2026.
  • NBC Securities bought 5,000 Prime Medicine shares in Q2 2026, an estimated $16.6K.
  • Prime Medicine made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1409 holding.
  • NBC Securities first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • NBC Securities's Prime Medicine position peaked at $41.5K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.